Dexcom announced the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes will ...

The global Blood Glucose Monitoring System Market, valued at US$15.16 billion in 2024, stood at US$16.46 billion in 2025 and ...

Dexcom’s “Smart Basal” has received FDA clearance for people with type 2 diabetes using long-acting insulin. The feature will ...

A medical technology firm specialising in continuous glucose monitoring systems for diabetes is set to relocate to Maxis Business Park in Bracknell.

However, not all companies with momentum are long-term winners, and many investors have lost money by following short-term ...

Kessler Topaz Meltzer & Check, LLP encourages DexCom investors who have suffered significant losses to contact the firm directly to acquire more information. CLICK HERE TO SIGN UP FOR THE CASE OR GO ...

If you are a new investor, healthcare stocks can provide numerous diversification benefits to your portfolio and help enhance ...

An off-price apparel retailer benefitted from solid results and an improved outlook on Friday, Nov. 21, 2025, while losses ...

You can keep chasing symptoms, or you can start with your brain first, where health actually begins. That's the philosophy ...

Diabetes care can greatly benefit from the implementation of telemedicine, but older adults still face accessibility barriers.

From periodised carbohydrates to gut training, here we reveal the nutritional methods that Remco Evenepoel’s new team hope ...